Anchorage Capital Partners
Overview
Anchorage Capital Partners is a Sydney-based private equity firm that specializes in buyout investments in the lower mid-market across Australia and New Zealand.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Meril Life Sciences | Feb 2022 | Private Equity | Co-investor |
For institutional investors. Book with your work email.
Key People
Ed Bostock
Managing Partner
Elizabeth Zhang
Investor Relations
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Anchorage Capital Partners based?
Anchorage Capital Partners is headquartered in Sydney, Australia.
When was Anchorage Capital Partners founded?
Anchorage Capital Partners was founded in 2007.
How many portfolio companies does Anchorage Capital Partners have?
Anchorage Capital Partners has 3 portfolio companies in Caplight's dataset.
What are some companies in Anchorage Capital Partners's portfolio?
Portfolio companies visible on Caplight include Meril Life Sciences.
What was Anchorage Capital Partners's most recent investment shown here?
Anchorage Capital Partners's most recent investment in this portfolio sample was in Meril Life Sciences in 2022.
What sectors does Anchorage Capital Partners focus on?
Anchorage Capital Partners focuses on Consumer & Commerce, Healthcare & Life Sciences, FinTech, Enterprise Software.
What company stages does Anchorage Capital Partners focus on?
Anchorage Capital Partners typically invests at the Late stage.
What is Anchorage Capital Partners's AUM?
Anchorage Capital Partners's assets under management are estimated between $660.0M and $792.0M.